JIYA ACQUISITION CORP's ticker is JYAC and the CUSIP is 47760M102. A total of 59 filers reported holding JIYA ACQUISITION CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $488,000 | -2.8% | 48,930 | -3.7% | 0.10% | +2.1% |
| Q2 2022 | $502,000 | +0.6% | 50,830 | 0.0% | 0.09% | -4.1% |
| Q1 2022 | $499,000 | +0.4% | 50,830 | 0.0% | 0.10% | -8.4% |
| Q4 2021 | $497,000 | -6.6% | 50,830 | -7.1% | 0.11% | -16.4% |
| Q3 2021 | $532,000 | -2.2% | 54,690 | 0.0% | 0.13% | -5.9% |
| Q2 2021 | $544,000 | -3.4% | 54,690 | -4.4% | 0.14% | -11.1% |
| Q1 2021 | $563,000 | -10.1% | 57,210 | -5.9% | 0.15% | -50.8% |
| Q4 2020 | $626,000 | – | 60,800 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 562,500 | $5,524,000 | 2.58% |
| Samsara BioCapital, LLC | 507,041 | $4,984,000 | 1.26% |
| Altium Capital Management LP | 200,000 | $1,966,000 | 0.66% |
| Bain Capital Life Sciences Investors, LLC | 300,000 | $2,949,000 | 0.29% |
| GLAZER CAPITAL, LLC | 1,003,386 | $9,853,000 | 0.28% |
| Integrity Capital Management (HK) Ltd | 5,000 | $49,000 | 0.25% |
| Spartan Fund Management Inc. | 100,000 | $1,228,000 | 0.20% |
| Context Capital Management, LLC | 300,000 | $2,949,000 | 0.19% |
| PFM Health Sciences, LP | 464,103 | $4,562,000 | 0.17% |
| EcoR1 Capital, LLC | 500,000 | $4,915,000 | 0.15% |